{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:01:26Z","timestamp":1787014886211,"version":"build-2736575974"},"reference-count":39,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2004,4,14]],"date-time":"2004-04-14T00:00:00Z","timestamp":1081900800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J American Geriatrics Society"],"published-print":{"date-parts":[[2004,5]]},"abstract":"<jats:p>\n                    <jats:bold>Objectives:<\/jats:bold>\n                    To study the association between hospital admission for lithium toxicity and the use of diuretics, angiotensin\u2010converting enzyme (ACE) inhibitors, and nonsteroidal antiinflammatory drugs (NSAIDs) in the elderly.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Design:<\/jats:bold>\n                    Population\u2010based nested case\u2010control study.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Setting:<\/jats:bold>\n                    Ontario, Canada.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Participants:<\/jats:bold>\n                    Ontario residents aged 66 and older treated with lithium.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Measurements:<\/jats:bold>\n                    Estimated relative risk of hospital admission for lithium toxicity.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    From January 1992 to December 2001, 10,615 elderly patients continuously receiving lithium were identified, of whom 413 (3.9%) were admitted to the hospital at least once for lithium toxicity. After adjustment for potential confounders, a dramatically increased risk of lithium toxicity was seen within a month of initiating treatment with a loop diuretic (relative risk (RR)=5.5, 95% confidence interval (CI)=1.9\u201316.1) or an ACE inhibitor (RR=7.6, 95% CI=2.6\u201322.0). Conversely, neither thiazide diuretics nor NSAIDs were independently associated with a significantly increased risk of hospitalization for lithium toxicity.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    The use of loop diuretics or ACE inhibitors significantly increases the risk of hospitalization for lithium toxicity, particularly in na\u00efve recipients.\n                  <\/jats:p>","DOI":"10.1111\/j.1532-5415.2004.52221.x","type":"journal-article","created":{"date-parts":[[2004,4,14]],"date-time":"2004-04-14T09:37:00Z","timestamp":1081935420000},"page":"794-798","source":"Crossref","is-referenced-by-count":147,"title":["Drug\u2010Induced Lithium Toxicity in the Elderly: A Population\u2010Based Study"],"prefix":"10.1111","volume":"52","author":[{"given":"David N.","family":"Juurlink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad M.","family":"Mamdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula A.","family":"Rochon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth I.","family":"Shulman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald A.","family":"Redelmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,4,14]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199529030-00004"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8627(20)30440-5"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1977.102"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/gps.452"},{"key":"e_1_2_6_6_2","first-page":"1439","article-title":"Lithium nephrotoxicity","volume":"11","author":"Markowitz GS","year":"2000","journal-title":"A progressive combined glomerular and tubulointerstitial nephropathy"},{"key":"e_1_2_6_7_2","first-page":"283","article-title":"Irreversible lithium neurotoxicity","volume":"20","author":"Kores B","year":"1997","journal-title":"An overview"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410360621"},{"key":"e_1_2_6_9_2","first-page":"93","article-title":"Lithium nephrotoxicity","volume":"42","author":"Walker RG.","year":"1993","journal-title":"Kidney Int Suppl"},{"key":"e_1_2_6_10_2","first-page":"394","article-title":"Lithium treatment and the geriatric population","volume":"28","author":"De Angelis L.","year":"1990","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"e_1_2_6_11_2","first-page":"94","article-title":"Adverse effects of lithium therapy in the acutely ill elderly patient","volume":"43","author":"Smith RE","year":"1982","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_6_12_2","first-page":"833","article-title":"Lithium toxicity","volume":"35","author":"Oakley PW","year":"2001","journal-title":"An iatrogenic problem in susceptible individuals"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199410060-00004"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.56.661.783"},{"key":"e_1_2_6_15_2","first-page":"439","article-title":"Lithium toxicity precipitated by diuretics","volume":"72","author":"Lutz EG.","year":"1975","journal-title":"J Med Soc N J"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.281.6236.371"},{"key":"e_1_2_6_17_2","first-page":"68","article-title":"Lithium and angiotensin\u2010converting enzyme inhibitors","volume":"16","author":"Finley PR","year":"1996","journal-title":"Evaluation of a potential interaction"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199325010-00003"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(92)90693-6"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.1990.11716327"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.139.8.1082b"},{"key":"e_1_2_6_22_2","first-page":"509","article-title":"NSAID\u2010related adverse drug interactions with clinical relevance. An update","volume":"32","author":"Johnson AG","year":"1994","journal-title":"Int J Clin Pharmacol Ther"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199308020-00002"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199010000-00009"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-198909000-00042"},{"key":"e_1_2_6_26_2","first-page":"337","article-title":"Recent patterns of medication use in the ambulatory adult population of the United States","volume":"287","author":"Kaufman DW","year":"2002","journal-title":"The Slone survey"},{"key":"e_1_2_6_27_2","unstructured":"International Classification of Diseases Ninth Revision Clinical Modification 6th Ed. Washington DC: Public Health Service 2000."},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1987.tb01353.x"},{"key":"e_1_2_6_29_2","first-page":"635","article-title":"Lithium and calcium channel blockers","volume":"30","author":"Wright BA","year":"1991","journal-title":"Possible neurotoxicity"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1986.tb02980.x"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.151.2.373"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1177\/070674378402900711"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-979328"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.137.6.736"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.153.9.1233"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.88.1.15"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/154.9.854"},{"key":"e_1_2_6_38_2","first-page":"289","article-title":"Frusemide","volume":"5","author":"Saffer D","year":"1983","journal-title":"A safe diuretic during lithium therapy?"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.148.8.1060"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200016030-00002"}],"container-title":["Journal of the American Geriatrics Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1532-5415.2004.52221.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1532-5415.2004.52221.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T13:42:15Z","timestamp":1762177335000},"score":1,"resource":{"primary":{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/10.1111\/j.1532-5415.2004.52221.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4,14]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["10.1111\/j.1532-5415.2004.52221.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1532-5415.2004.52221.x","archive":["Portico"],"relation":{},"ISSN":["0002-8614","1532-5415"],"issn-type":[{"value":"0002-8614","type":"print"},{"value":"1532-5415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4,14]]}}}